Correlation Between Century Therapeutics and GlycoMimetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and GlycoMimetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and GlycoMimetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and GlycoMimetics, you can compare the effects of market volatilities on Century Therapeutics and GlycoMimetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of GlycoMimetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and GlycoMimetics.

Diversification Opportunities for Century Therapeutics and GlycoMimetics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Century and GlycoMimetics is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and GlycoMimetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlycoMimetics and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with GlycoMimetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlycoMimetics has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and GlycoMimetics go up and down completely randomly.

Pair Corralation between Century Therapeutics and GlycoMimetics

Given the investment horizon of 90 days Century Therapeutics is expected to under-perform the GlycoMimetics. But the stock apears to be less risky and, when comparing its historical volatility, Century Therapeutics is 8.41 times less risky than GlycoMimetics. The stock trades about -0.01 of its potential returns per unit of risk. The GlycoMimetics is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest  17.00  in GlycoMimetics on August 29, 2024 and sell it today you would earn a total of  15.00  from holding GlycoMimetics or generate 88.24% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  GlycoMimetics

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Century Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
GlycoMimetics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in GlycoMimetics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, GlycoMimetics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Century Therapeutics and GlycoMimetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and GlycoMimetics

The main advantage of trading using opposite Century Therapeutics and GlycoMimetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, GlycoMimetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlycoMimetics will offset losses from the drop in GlycoMimetics' long position.
The idea behind Century Therapeutics and GlycoMimetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins